Located within the Department of Developmental Biology
and initiated with support from the Office of the Senior
Vice Chancellor, NHLBI P30 funding, and the University of
Pittsburgh Clinical and Translational Science Institute
the Stem Cell Core is committed to support human
iPS cell research at the University of Pittsburgh
and beyond. By facilitating the derivation and distribution
of human iPS cell lines, the Stem Cell Core will accelerate
stem cell research and provide unique opportunities for
human disease modeling. The work scope of the Stem Cell
Core Facility will include the following:
- Derivation and distribution of human iPS cells.
- Develop cutting edge stem cell technologies and establish new iPS and stem differentiation protocols for human disease modeling.
- Provide seminars, workshops, and hands on training on stem cell research.
- Provide consultation on stem cell research protocol design and grant preparation planning.
- Hub of regulatory and technical information relating to human stem cell research.
- Validate stem cell reagents and negotiate reduced reagent pricing for Pitt research community.
- Work with CTSI to guide the clinical research community on stem cell core services, training opportunities, emerging technologies and pilot funding.
The Stem Cell Core has successfully derived pig iPS cells from pig ear fibroblasts with
support of the 2011 CTSI Translational Technologies Core Pilot (T2CP2) grant.